Daniel R Chevallard's Net Worth
Daniel R Chevallard's net worth is estimated to be at least $170,143.03 as of 12/23/2024. CoreStreet's estimation of Daniel R Chevallard's net worth is based on their sale of stock and current holding of stock.
Daniel R Chevallard is CFO at Viracta Therapeutics Inc. They have executed at least 15 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,405 units of VIRX stock on 02/27/2024. Their biggest sale was on 11/29/2021 when they sold 4,325 units of Viracta Therapeutics Inc stock for $20,846.50. They typically trade 2 times per year.
Total value of insider buys:
- $49,999.95
Total value of insider sells:
- $120,143.08
Most recent insider trade:
- Feb. 27, 2024
Daniel R Chevallard's Insider Trading History
| Viracta Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 27, 2024 | CFO | 3,405 | $0.73 | Sell | $2,485.65 |
Nov. 28, 2023 | CFO | 3,720 | $0.50 | Sell | $1,860.00 |
Aug. 28, 2023 | CFO | 3,512 | $1.45 | Sell | $5,092.40 |
May 25, 2023 | CFO | 3,635 | $1.42 | Sell | $5,161.70 |
Feb. 27, 2023 | CFO | 3,599 | $1.68 | Sell | $6,046.32 |
Nov. 28, 2022 | CFO | 3,532 | $2.72 | Sell | $9,607.04 |
Aug. 26, 2022 | CFO | 3,655 | $4.02 | Sell | $14,693.10 |
May 26, 2022 | CFO | 3,596 | $1.90 | Sell | $6,832.40 |
Feb. 28, 2022 | CFO | 3,998 | $2.78 | Sell | $11,114.44 |
Nov. 29, 2021 | CFO | 4,325 | $4.82 | Sell | $20,846.50 |
Nov. 26, 2021 | CFO | 3,254 | $4.80 | Sell | $15,619.20 |
| Regulus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 1, 2019 | CFO | 2,669 | $1.31 | Sell | $3,496.39 |
May 15, 2019 | CFO | 10,000 | $1.41 | Sell | $14,100.00 |
April 1, 2019 | CFO | 3,253 | $0.98 | Sell | $3,187.94 |
July 25, 2017 | CFO | 54,945 | $0.91 | Buy | $49,999.95 |